The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
“Inflammaging” as a druggable target: a senescence-associated secretory phenotype-centered view of type 2 diabetes
Open accessAbstract
Aging is a complex phenomenon driven by a variety of molecular alterations. A relevant feature of aging is chronic low‐grade inflammation, termed “inflammaging.” In type 2 diabetes mellitus (T2DM), many elements of aging appear earlier or are overrepresented, including consistent inflammaging. T2DM patients have an increased death rate, associated with an incremented inflammatory score. The source of this inflammation is debated. Recently, the senescence‐associated secretory phenotype (SASP) has been proposed as the main origin of inflammaging in both aging and T2DM. Different pathogenic mechanisms linked to T2DM progression and complications development have been linked to senescence and SASP, that is, oxidative stress and endoplasmic reticulum (ER) stress. Here we review the latest data connecting oxidative and ER stress with the SASP in the context of aging and T2DM, with emphasis on endothelial cells (ECs) and endothelial dysfunction. Moreover, since current medical practice is insufficient to completely suppress the increased death rate of diabetic patients, we propose a SASP‐centered view of T2DM as a futuristic therapeutic option, possibly opening new prospects by moving the attention from one‐organ studies of diabetes complications to a wider targeting of the aging process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent SASP elements in the majority of senescent cells are IL-1α, IL-1β, IL-6, IL-8, IL-18, and TNF-α,15,105,110 all of which are clinically validated CVD risk factors.1,5”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 2×
“The rate of senescent cell accumulation in the body depends on the balance between pro- and antisenescence stimuli [20].”
Background10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · cited 4×
“Inflammation is a nonspecific stereotypical response elicited by a variety of stimuli, many of which have been implicated in aging and T2DM [1, 2].”
BackgroundInfluentialSelf-citationCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Franceschi, C., & Campisi, J. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu057 · Cited by 3,891 · cited 4×
“Inflammation is a nonspecific stereotypical response elicited by a variety of stimuli, many of which have been implicated in aging and T2DM [1, 2].”
BackgroundInfluentialRapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · cited 1×
“Finally, highly interesting results in terms of SASP suppression have been obtained with the mTOR inhibitor rapamycin [48, 49], which has long been known to extend lifespan and healthspan in mice [50].”
BackgroundClearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“Notably, in animal models removal of senescent cells is sufficient to prolong lifespan and healthspan, as described in mice models of accelerated aging (INK-ATTAC mice) and in models of physiological aging [31, 32].”
BackgroundNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 11×
“senescent cells and determine their functional significance in vivo [26].”
BackgroundMethodInfluentialA complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038 · cited 2×
“[42] T.”
BackgroundEsposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961 · cited 1×
“hyperglycemia, also in an acute manner, through an oxidative mechanism, whose effect is more marked in subjects with impaired glucose tolerance [59].”
BackgroundSelf-citationNLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Tschopp, J., & Schroder, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2725 · Cited by 1,850 · cited 1×
“In turn, it is widely accepted that oxidative stress and macromolecular damage play a major role in controlling the inflammasome platform [75, 78, 79], mainly through the Trx/TXNIP complex, linking redox status, ER stress, and inflammation.”
BackgroundClearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819 · cited 1×
“The most promising strategies involve delaying cellular senescence [30]; SASP switch-off [48, 49]; SASP factor modulation [34, 47]; and selective removal or killing of existing senescent cells (senolytics or senotherapy) [25, 54].”
BackgroundInterleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774 · cited 4×
“Cellular senescence is associated with the acquisition of the SASP, which is characterized by the activation of a proinflammatory transcriptional program and is held to drive ARD development through chronic secretion of a variety of factors [1, 25, 26].”
BackgroundInfluentialmTOR is a key modulator of ageing and age-related disease
Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013) · Nature · doi:10.1038/nature11861 · Cited by 1,676 · cited 1×
“These changes have recently been related to the onset of a proinflammatory program in ECs and vessel wall cells [18].”
BackgroundInflammatory networks during cellular senescence: causes and consequences.
Freund, A., Orjalo, A. V., Desprez, P.-Y., & Campisi, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.003 · Cited by 1,354 · cited 2×
“Some of these cytokines can induce or reinforce the senescent phenotype by acting in an autocrine and paracrine manner, spreading senescence via a “bystander effect” [36].”
BackgroundLaberge, R.-M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3195 · Cited by 1,160 · cited 3×
“mTOR controls SASP protein secretion by enhancing IL-1α andMAP kinaseactivated protein kinase 2 (MAPKAP2) translation [48, 49].”
Background(2012) · The Lancet · doi:10.1016/s0140-6736(12)60110-x · Cited by 1,146 · cited 1×
“…Politecnica delle Marche, 60126 Ancona, Italy 3IRCCS Multimedica Group, 60126 Sesto San Giovanni, Italy 4Center of Clinical Pathology and Innovative Therapy, Italian National Research Center on Aging (INRCA-IRCCS), 60121 Ancona, Italy Correspondence should be addressed to Francesco…”
BackgroundThe NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Schroder, K., Zhou, R., & Tschopp, J. (2010) · Science · doi:10.1126/science.1184003 · Cited by 1,134
Fat tissue, aging, and cellular senescence
Tchkonia, T., Morbeck, D. E., Von Zglinicki, T., Van Deursen, J., Lustgarten, J., Scrable, H., Khosla, S., Jensen, M. D., & Kirkland, J. L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00608.x · Cited by 1,094
Freund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039 · cited 1×
“Upstream, p38 [44], JAK [45], and other MAP kinases [46], are all involved in SASP induction and control.”
BackgroundRegulated Ire1-dependent decay of messenger RNAs in mammalian cells
Hollien, J., Lin, J. H., Li, H., Stevens, N., Walter, P., & Weissman, J. S. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200903014 · Cited by 1,030
p16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · cited 1×
“As regards pancreatic β-cells, even though aging in itself does not appear to be critical in inducing tissue dysfunction [69, 70], increased β-cell senescence during aging and a limited regenerative potential have been described in senescent mouse pancreas [71].”
BackgroundRidker, P. M. (2016) · Circulation Research · doi:10.1161/circresaha.115.306656 · Cited by 1,002 · cited 1×
“The three licensed anti-TNF-α biologics have shown effectiveness in improving endothelial function; similar results have been obtained with anti-IL-6 treatment [88].”
ResultXu, M., Tchkonia, T., Ding, H., Ogrodnik, M., Lubbers, E. R., Pirtskhalava, T., White, T. A., Johnson, K. O., Stout, M. B., Mezera, V., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515386112 · Cited by 915 · cited 1×
“Upstream, p38 [44], JAK [45], and other MAP kinases [46], are all involved in SASP induction and control.”
BackgroundSesso, H. D. (2008) · JAMA · doi:10.1001/jama.2008.600 · Cited by 913 · cited 1×
“However, clinical studies have failed to confirm the benefit of antioxidants and vitamins in cardiovascular disease prevention and management [101].”
BackgroundHypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH
Zhang, G., Li, J., Purkayastha, S., Tang, Y., Zhang, H., Yin, Y., Li, B., Liu, G., & Cai, D. (2013) · Nature · doi:10.1038/nature12143 · Cited by 834
Wang, Y., Xu, C.-F., Liu, Y.-J., Mao, Y.-F., Lv, Z., Li, S.-Y., Zhu, X.-Y., & Jiang, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477112 · Cited by 825
Inflammatory Markers and Risk of Type 2 Diabetes
Wang, X., Bao, W., Liu, J., OuYang, Y.-Y., Wang, D., Rong, S., Xiao, X., Shan, Z.-L., Zhang, Y., Yao, P., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0702 · Cited by 820
Chronic inflammation induces telomere dysfunction and accelerates ageing in mice
Jurk, D., Wilson, C., Passos, J. F., Oakley, F., Correia-Melo, C., Greaves, L., Saretzki, G., Fox, C., Lawless, C., Anderson, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5172 · Cited by 819 · cited 2×
“In animal models, the number of senescent cells in specific organs predicts lifespan [30].”
BackgroundmTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Herranz, N., Gallage, S., Mellone, M., Wuestefeld, T., Klotz, S., Hanley, C. J., Raguz, S., Acosta, J. C., Innes, A. J., Banito, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3225 · Cited by 788 · cited 3×
“mTOR controls SASP protein secretion by enhancing IL-1α andMAP kinaseactivated protein kinase 2 (MAPKAP2) translation [48, 49].”
BackgroundSalminen, A., Kauppinen, A., & Kaarniranta, K. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.006 · Cited by 763 · cited 1×
“These findings clearly point at the endothelium as a key organ in the pathophysiology of aging and in diabetes complications.”
BackgroundAbderrazak, A., Syrovets, T., Couchie, D., El Hadri, K., Friguet, B., Simmet, T., & Rouis, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.01.008 · Cited by 732 · cited 1×
“In turn, it is widely accepted that oxidative stress and macromolecular damage play a major role in controlling the inflammasome platform [75, 78, 79], mainly through the Trx/TXNIP complex, linking redox status, ER stress, and inflammation.”
BackgroundInterleukin-6 in Aging and Chronic Disease: A Magnificent Pathway
Maggio, M., Guralnik, J. M., Longo, D. L., & Ferrucci, L. (2006) · The Journals of Gerontology: Series A · doi:10.1093/gerona/61.6.575 · Cited by 692 · cited 2×
“…Politecnica delle Marche, 60126 Ancona, Italy 3IRCCS Multimedica Group, 60126 Sesto San Giovanni, Italy 4Center of Clinical Pathology and Innovative Therapy, Italian National Research Center on Aging (INRCA-IRCCS), 60121 Ancona, Italy Correspondence should be addressed to Francesco…”
BackgroundTargeting inflammation in the treatment of type 2 diabetes: time to start
Donath, M. Y. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4275 · Cited by 690 · cited 1×
“Different pathogenicmechanisms linked to T2DM progression and complications development have been linked to senescence and SASP, that is, oxidative stress and endoplasmic reticulum (ER) stress.”
BackgroundEndoplasmic reticulum stress, obesity and diabetes
Cnop, M., Foufelle, F., & Velloso, L. A. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.07.010 · Cited by 682 · cited 9×
“Chronic ER stress and UPR activation may also result in ROS buildup, which induces a state of oxidative stress [115].”
BackgroundInfluentialCanonical Nlrp3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in Aging
Youm, Y.-H., Grant, R. W., McCabe, L. R., Albarado, D. C., Nguyen, K. Y., Ravussin, A., Pistell, P., Newman, S., Carter, R., Laque, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.010 · Cited by 674 · cited 1×
“These changes have recently been related to the onset of a proinflammatory program in ECs and vessel wall cells [18].”
BackgroundOrjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K., & Campisi, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905299106 · Cited by 654
Moiseeva, O., Deschênes‐Simard, X., St‐Germain, E., Igelmann, S., Huot, G., Cadar, A. E., Bourdeau, V., Pollak, M. N., & Ferbeyre, G. (2013) · Aging Cell · doi:10.1111/acel.12075 · Cited by 654
Structure, Function, and Inhibition of Chemokines
Fernandez, E. J., & Lolis, E. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091901.115838 · Cited by 609 · cited 1×
“For instance, CXC-type cytokines such as IL-8 require the formation of two disulfide bonds for folding and function [121].”
BackgroundMetabolic Syndrome, Aging and Involvement of Oxidative Stress
Bonomini, F., Rodella, L. F., & Rezzani, R. (2015) · Aging and Disease · doi:10.14336/ad.2014.0305 · Cited by 599 · cited 1×
“Significantly, at least two major molecular changes responsible for diabetes complications and also associated with physiological aging and T2DM, that is, oxidative stress and endoplasmic reticulum (ER) stress [10, 11], have recently been related to senescence acquisition and/or SASP modulation [12, 13].”
BackgroundBRANDES, R., FLEMING, I., & BUSSE, R. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.027 · Cited by 563 · cited 1×
“There is growing epidemiological evidence that a state of mild inflammation is associated with and predicts several age-related diseases (ARDs), including type 2 diabetes mellitus (T2DM) and its complications (e.g., cardiac death) [3–5].”
BackgroundCoordination of ER and oxidative stress signaling: The PERK/Nrf2 signaling pathway
Cullinan, S. B., & Diehl, J. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.09.018 · Cited by 554 · cited 1×
“Chronic ER stress and UPR activation may also result in ROS buildup, which induces a state of oxidative stress [115].”
BackgroundSynthetic lethal metabolic targeting of cellular senescence in cancer therapy
Dörr, J. R., Yu, Y., Milanovic, M., Beuster, G., Zasada, C., Däbritz, J. H. M., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., et al. (2013) · Nature · doi:10.1038/nature12437 · Cited by 541 · cited 1×
“Finally, an agent interfering with the glycolysis pathway (2-deoxyglucose) has been shown to selectively affect senescent cells by exerting an antisurvival action, thus attenuating inflammation [97].”
BackgroundRidker, P. M., Howard, C. P., Walter, V., Everett, B., Libby, P., Hensen, J., & Thuren, T. (2012) · Circulation · doi:10.1161/circulationaha.112.122556 · Cited by 530
Huang, E. S., Laiteerapong, N., Liu, J. Y., John, P. M., Moffet, H. H., & Karter, A. J. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12956 · Cited by 501 · cited 1×
“The life expectancy of T2DM patients is about 6 years shorter than that of nondiabetic individuals of similar age [6].”
BackgroundStress-Response Hormesis and Aging: “That which Does Not Kill Us Makes Us Stronger”
Gems, D., & Partridge, L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.01.001 · Cited by 498
Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss
Gregor, M. F., Yang, L., Fabbrini, E., Mohammed, B. S., Eagon, J. C., Hotamisligil, G. S., & Klein, S. (2009) · Diabetes · doi:10.2337/db08-1220 · Cited by 488 · cited 1×
“UPR markers are overexpressed in the liver and adipose tissue of diabetic rodents [113] as well as in ex vivo samples from T2DM patients [114].”
BackgroundDiabetes and the Brain: Oxidative Stress, Inflammation, and Autophagy
Muriach, M., Flores-Bellver, M., Romero, F. J., & Barcia, J. M. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/102158 · Cited by 482 · cited 1×
“Significantly, at least two major molecular changes responsible for diabetes complications and also associated with physiological aging and T2DM, that is, oxidative stress and endoplasmic reticulum (ER) stress [10, 11], have recently been related to senescence acquisition and/or SASP modulation [12, 13].”
BackgroundAre senescence and exhaustion intertwined or unrelated processes that compromise immunity?
Akbar, A. N., & Henson, S. M. (2011) · Nature Reviews Immunology · doi:10.1038/nri2959 · Cited by 474 · cited 1×
“These findings clearly point at the endothelium as a key organ in the pathophysiology of aging and in diabetes complications.”
BackgroundCellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
Palmer, A. K., Tchkonia, T., LeBrasseur, N. K., Chini, E. N., Xu, M., & Kirkland, J. L. (2015) · Diabetes · doi:10.2337/db14-1820 · Cited by 423
Toso, A., Revandkar, A., Di Mitri, D., Guccini, I., Proietti, M., Sarti, M., Pinton, S., Zhang, J., Kalathur, M., Civenni, G., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.044 · Cited by 418 · cited 2×
“, MCP-1), indicating that selective SASP modulation could be feasible [47].”
BackgroundDiabetes recovery by age-dependent conversion of pancreatic δ-cells into insulin producers
Chera, S., Baronnier, D., Ghila, L., Cigliola, V., Jensen, J. N., Gu, G., Furuyama, K., Thorel, F., Gribble, F. M., Reimann, F., et al. (2014) · Nature · doi:10.1038/nature13633 · Cited by 410
DNA damage checkpoints in stem cells, ageing and cancer
Sperka, T., Wang, J., & Rudolph, K. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3420 · Cited by 393 · cited 1×
“, radiation, hyperglycemia, oxidative stress, and ER stress) [51], suggesting a close”
BackgroundHaendeler, J., Hoffmann, J., Diehl, J. F., Vasa, M., Spyridopoulos, I., Zeiher, A. M., & Dimmeler, S. (2004) · Circulation Research · doi:10.1161/01.res.0000121104.05977.f3 · Cited by 384
Denoyelle, C., Abou-Rjaily, G., Bezrookove, V., Verhaegen, M., Johnson, T. M., Fullen, D. R., Pointer, J. N., Gruber, S. B., Su, L. D., Nikiforov, M. A., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1471 · Cited by 349
Endothelial dysfunction and aging: An update
Herrera, M. D., Mingorance, C., Rodríguez-Rodríguez, R., & Alvarez de Sotomayor, M. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2009.07.002 · Cited by 322 · cited 1×
“Aging is an intricate process that results from a combination of environmental, genetic, epigenetic, and stochastic factors [1].”
BackgroundNew insights into ER stress-induced insulin resistance
Flamment, M., Hajduch, E., Ferré, P., & Foufelle, F. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.06.003 · Cited by 306 · cited 7×
“Chronic ER stress and UPR activation may also result in ROS buildup, which induces a state of oxidative stress [115].”
BackgroundInfluentialZhao, C., Yasumura, D., Li, X., Matthes, M., Lloyd, M., Nielsen, G., Ahern, K., Snyder, M., Bok, D., Dunaief, J. L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44303 · Cited by 303 · cited 1×
“Prevention of age-related macular degeneration-like retinopathy by rapamycin has also been reported [93].”
BackgroundAccelerated senescence in the kidneys of patients with type 2 diabetic nephropathy
Verzola, D., Gandolfo, M. T., Gaetani, G., Ferraris, A., Mangerini, R., Ferrario, F., Villaggio, B., Gianiorio, F., Tosetti, F., Weiss, U., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90302.2008 · Cited by 302 · cited 1×
“After the initial in vitro demonstration that exposure to high glucose levels induces EC senescence [72], in vivo evidence of increased senescence has been provided in atherosclerotic plaques and kidney tissue of diabetes patients, suggesting the relevance of this phenomenon to T2DM vascular complications [73, 74].”
BackgroundEndoplasmic reticulum stress and atherosclerosis
Hotamisligil, G. S. (2010) · Nature Medicine · doi:10.1038/nm0410-396 · Cited by 299 · cited 1×
“The reduced molecular oxygen accumulates during increased protein folding due to UPR activation, resulting in cell toxicity [116].”
BackgroundVillaret, A., Galitzky, J., Decaunes, P., Estève, D., Marques, M.-A., Sengenès, C., Chiotasso, P., Tchkonia, T., Lafontan, M., Kirkland, J. L., et al. (2010) · Diabetes · doi:10.2337/db10-0398 · Cited by 282 · cited 1×
“Evidence of significant in situ senescence of cells with a functional SASP in adipose tissue (mainly ECs and adipocyte progenitors) from obese subjects has been linked to T2DM development [37, 68].”
BackgroundThe number of p16INK4a positive cells in human skin reflects biological age
Waaijer, M. E. C., Parish, W. E., Strongitharm, B. H., van Heemst, D., Slagboom, P. E., de Craen, A. J. M., Sedivy, J. M., Westendorp, R. G. J., Gunn, D. A., & Maier, A. B. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00837.x · Cited by 264 · cited 1×
“Evidence that the number of senescent dermal fibroblasts correlates with ARD incidence has also been provided in humans [33].”
BackgroundEndothelium and Its Alterations in Cardiovascular Diseases: Life Style Intervention
Favero, G., Paganelli, C., Buffoli, B., Rodella, L. F., & Rezzani, R. (2014) · BioMed Research International · doi:10.1155/2014/801896 · Cited by 252 · cited 1×
“There is growing epidemiological evidence that a state of mild inflammation is associated with and predicts several age-related diseases (ARDs), including type 2 diabetes mellitus (T2DM) and its complications (e.g., cardiac death) [3–5].”
BackgroundJimenez-Gomez, Y., Mattison, J. A., Pearson, K. J., Martin-Montalvo, A., Palacios, H. H., Sossong, A. M., Ward, T. M., Younts, C. M., Lewis, K., Allard, J. S., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.004 · Cited by 240
Donato, A. J., Black, A. D., Jablonski, K. L., Gano, L. B., & Seals, D. R. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00438.x · Cited by 237 · cited 1×
“Interestingly, a decrease in complexity seems to arise earlier in diabetes patients [7], suggesting that under some respects diabetes may provide an interesting model of “accelerated aging.””
BackgroundNew Insights for Oxidative Stress and Diabetes Mellitus
Maiese, K. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/875961 · Cited by 226 · cited 1×
“Among nutrient-sensitive factors, sirtuins, a family of NAD-dependent deacetylases with epigenetic modulation activity, can prevent vascular endothelial replicative senescence by increasing antioxidant defense [109, 110].”
BackgroundEndothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation
Rodríguez‐Mañas, L., El‐Assar, M., Vallejo, S., López‐Dóriga, P., Solís, J., Petidier, R., Montes, M., Nevado, J., Castro, M., Gómez‐Guerrero, C., et al. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00466.x · Cited by 224 · cited 2×
“[15] L.”
BackgroundBrodsky, S. V., Gealekman, O., Chen, J., Zhang, F., Togashi, N., Crabtree, M., Gross, S. S., Nasjletti, A., & Goligorsky, M. S. (2004) · Circulation Research · doi:10.1161/01.res.0000111802.09964.ef · Cited by 213 · cited 1×
“EC senescence, with p53 and p16 upregulation in endothelium, also occurs in the arteries of rats with T2DM [106].”
BackgroundEpigenetics: Mechanisms and Implications for Diabetic Complications
Cooper, M. E., & El-Osta, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.223552 · Cited by 213
Avrahami, D., Li, C., Zhang, J., Schug, J., Avrahami, R., Rao, S., Stadler, M. B., Burger, L., Schübeler, D., Glaser, B., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.025 · Cited by 207
Mattison, J. A., Wang, M., Bernier, M., Zhang, J., Park, S.-S., Maudsley, S., An, S. S., Santhanam, L., Martin, B., Faulkner, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.018 · Cited by 206 · cited 3×
“Among nutrient-sensitive factors, sirtuins, a family of NAD-dependent deacetylases with epigenetic modulation activity, can prevent vascular endothelial replicative senescence by increasing antioxidant defense [109, 110].”
BackgroundChen, H., Ruiz, P. D., McKimpson, W. M., Novikov, L., Kitsis, R. N., & Gamble, M. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.011 · Cited by 205 · cited 1×
“…to completely suppress the increased death rate of diabetic patients, we propose a SASP-centered view of T2DM as a futuristic therapeutic option, possibly opening new prospects by moving the attention from one-organ studies of diabetes complications to a wider targeting of the aging process.”
BackgroundAntioxidant Anti-Inflammatory Treatment in Type 2 Diabetes
Ceriello, A., & Testa, R. (2009) · Diabetes Care · doi:10.2337/dc09-s316 · Cited by 196 · cited 2×
“However, improvement of long-term outcomes in T2DM patients has not been detected [108].”
BackgroundSelf-citationDickinson, S., Hancock, D. P., Petocz, P., Ceriello, A., & Brand-Miller, J. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1188 · Cited by 184
Self-citationRedox signaling loops in the unfolded protein response
Higa, A., & Chevet, E. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.03.011 · Cited by 174 · cited 2×
“Disulfide bond rearrangement in the ER is catalyzed by protein disulfide isomerases (PDIs), which are critical for the folding of disulfidecontaining secreted factors [122].”
BackgroundInflammation: a culprit for vascular calcification in atherosclerosis and diabetes
Bessueille, L., & Magne, D. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1876-4 · Cited by 172 · cited 1×
“Moreover, mounting evidence suggests an important role for the inflammasome platform in both T2DM and atherosclerosis [75, 76].”
BackgroundThe emerging challenge in diabetes: The “metabolic memory”
Ceriello, A. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.05.005 · Cited by 170 · cited 1×
“The pathophysiology of T2DM complications is characterized by increased oxidative stress, nonenzymatic glycation, and PKC overactivation as the main molecular changes involving micro- and macrovascular compartments [89].”
BackgroundSelf-citationYokoi, T., Fukuo, K., Yasuda, O., Hotta, M., Miyazaki, J., Takemura, Y., Kawamoto, H., Ichijo, H., & Ogihara, T. (2006) · Diabetes · doi:10.2337/db05-1607 · Cited by 169
Hasegawa, Y., Saito, T., Ogihara, T., Ishigaki, Y., Yamada, T., Imai, J., Uno, K., Gao, J., Kaneko, K., Shimosawa, T., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.054346 · Cited by 169
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications
Herder, C., Dalmas, E., Böni-Schnetzler, M., & Donath, M. Y. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.08.001 · Cited by 168 · cited 1×
“Large clinical trials are exploring the potential of IL-1 antagonism to prevent cardiovascular and other diabetes complications [85].”
BackgroundZhao, J., Zhu, Y., Lin, J., Matsuguchi, T., Blackburn, E., Zhang, Y., Cole, S. A., Best, L. G., Lee, E. T., & Howard, B. V. (2014) · Diabetes · doi:10.2337/db13-0744 · Cited by 161
p53 Mediates the Accelerated Onset of Senescence of Endothelial Progenitor Cells in Diabetes
Rosso, A., Balsamo, A., Gambino, R., Dentelli, P., Falcioni, R., Cassader, M., Pegoraro, L., Pagano, G., & Brizzi, M. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509293200 · Cited by 159 · cited 1×
“Endothelial progenitor cells (EPCs) from diabetic donors undergo oxidative stress-induced premature senescence [105].”
BackgroundCeriello, A., Novials, A., Ortega, E., La Sala, L., Pujadas, G., Testa, R., Bonfigli, A. R., Esposito, K., & Giugliano, D. (2012) · Diabetes · doi:10.2337/db12-0224 · Cited by 155
Self-citationThe endoplasmic reticulum stress response and diabetic kidney disease
Cunard, R. A., & Sharma, K. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00021.2011 · Cited by 148 · cited 1×
“Altered nutrient availability, free fatty acids, cytokines, perturbations in calcium transients, oxidative stress, and hypoxia are all capable of triggering accumulation of unfolded ER proteins [118].”
BackgroundMammalian Target of Rapamycin Regulates Nox4-Mediated Podocyte Depletion in Diabetic Renal Injury
Eid, A. A., Ford, B. M., Bhandari, B. K., Cavaglieri, R. D. C., Block, K. L., Barnes, J. L., Gorin, Y. C., Choudhury, G. G., & Abboud, H. E. (2013) · Diabetes · doi:10.2337/db12-1504 · Cited by 146 · cited 1×
“For instance, rapamycin, the main SASP-suppressing agent, reduces renal hypertrophy in diabetic mice and slows the progression of diabetic kidney disease in rats, even without reducing blood glucose [92].”
BackgroundMetformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis
Forouzandeh, F., Salazar, G., Patrushev, N. A., Xiong, S., Hilenski, L. L., Fei, B., & Alexander, R. W. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001202 · Cited by 139 · cited 1×
“A putative antisenescence in vivo role [95] and an anti-SASP in vitro action [96] have been proposed for metformin, currently the most effective antidiabetes agent in terms of prevention of its vascular complications [91].”
BackgroundGene expression profiling of replicative and induced senescence
Purcell, M., Kruger, A., & Tainsky, M. A. (2014) · Cell Cycle · doi:10.4161/15384101.2014.973327 · Cited by 132 · cited 2×
“Indeed, the SASP involves release of hundreds of molecules [35–38], of which interleukin- (IL-) 1 α/β, IL-6, IL-8, transforming growth factor- (TGF-) β, and tumor necrosis factor- (TNF-) α are the most common and best characterized [35, 36, 38].”
BackgroundOmics technologies and the study of human ageing
Valdes, A. M., Glass, D., & Spector, T. D. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3553 · Cited by 129 · cited 1×
“, genomics, metabolomics, metagenomics, and transcriptomics) are being applied to discover such markers [55].”
BackgroundBlagosklonny, M. V. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.506 · Cited by 123
Perkisas, S., & Vandewoude, M. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2743 · Cited by 120 · cited 1×
“Different pathogenicmechanisms linked to T2DM progression and complications development have been linked to senescence and SASP, that is, oxidative stress and endoplasmic reticulum (ER) stress.”
BackgroundOlivieri, F., Spazzafumo, L., Bonafè, M., Recchioni, R., Prattichizzo, F., Marcheselli, F., Micolucci, L., Mensà, E., Giuliani, A., Santini, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6164 · Cited by 117 · cited 2×
“Epigenetic modifications leading to chronic inflammation have been described in ECs and immune cells of diabetes patients also in the absence of replicative senescence biomarkers [23, 57, 58].”
BackgroundSelf-citationHensen, J., Howard, C. P., Walter, V., & Thuren, T. Y. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.07.003 · Cited by 115
ROS ‐generating oxidases N ox1 and N ox4 contribute to oncogenic R as‐induced premature senescence
Kodama, R., Kato, M., Furuta, S., Ueno, S., Zhang, Y., Matsuno, K., Yabe‐Nishimura, C., Tanaka, E., & Kamata, T. (2012) · Genes to Cells · doi:10.1111/gtc.12015 · Cited by 115
Leukocyte telomere length is associated with complications of Type 2 diabetes mellitus
Testa, R., Olivieri, F., Sirolla, C., Spazzafumo, L., Rippo, M. R., Marra, M., Bonfigli, A. R., Ceriello, A., Antonicelli, R., Franceschi, C., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03370.x · Cited by 109 · cited 1×
“LTL is significantly shorter in T2DMpatients comparedwith controls over awide age range and is significantly associated with the presence and number of diabetes complications [65].”
BackgroundSelf-citationEpigenetic mechanisms of endothelial dysfunction in type 2 diabetes
Prattichizzo, F., Giuliani, A., Çeka, A., Rippo, M. R., Bonfigli, A. R., Testa, R., Procopio, A. D., & Olivieri, F. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0090-4 · Cited by 104 · cited 3×
“Epigenetic modifications leading to chronic inflammation have been described in ECs and immune cells of diabetes patients also in the absence of replicative senescence biomarkers [23, 57, 58].”
BackgroundSelf-citationNon-Cell-Autonomous Regulation of Cellular Senescence in Cancer
Mitri, D. D., & Alimonti, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.005 · Cited by 100 · cited 6×
“Therefore, different prosenescence stimuli may engage different pathways [26, 34], leading to partially different gene expression patterns [38].”
BackgroundInfluentialPrattichizzo, F., Giuliani, A., Recchioni, R., Bonafè, M., Marcheselli, F., Carolis, S. D., Campanati, A., Giuliodori, K., Rippo, M. R., Brugè, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7858 · Cited by 98
Self-citationLeukocyte telomere shortening in elderly Type2DM patients with previous myocardial infarction
Olivieri, F., Lorenzi, M., Antonicelli, R., Testa, R., Sirolla, C., Cardelli, M., Mariotti, S., Marchegiani, F., Marra, M., Spazzafumo, L., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.034 · Cited by 97 · cited 2×
“Finally, a strong association has been highlighted between telomere length and the presence of some diabetes complications and general arterial aging [66, 67].”
BackgroundSelf-citationAge-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity
Stepanova, M., Rodriguez, E., Birerdinc, A., & Baranova, A. V. (2015) · Oncotarget · doi:10.18632/oncotarget.2725 · Cited by 91 · cited 1×
“Anticytokine agents are commonly used to treat autoimmune diseases, which are characterized by chronic inflammation, endothelial dysfunction, accelerated aging, and a heavy burden of senescent cells [86, 87].”
BackgroundOlivieri, F., Lazzarini, R., Babini, L., Prattichizzo, F., Rippo, M. R., Tiano, L., Di Nuzzo, S., Graciotti, L., Festa, R., Brugè, F., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.033 · Cited by 84 · cited 1×
“In ECs this has clearly been demonstrated for coenzyme Q10 [98], N-acetyl cysteine [99], and a stable vitamin C analog [100].”
BackgroundSelf-citationNew insights into the roles of ATM and DNA-PKcs in the cellular response to oxidative stress
Chen, B. P. C., Li, M., & Asaithamby, A. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.004 · Cited by 84
Hayashi, T., Kotani, H., Yamaguchi, T., Taguchi, K., Iida, M., Ina, K., Maeda, M., Kuzuya, M., Hattori, Y., & Ignarro, L. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322153111 · Cited by 83 · cited 1×
“After the initial in vitro demonstration that exposure to high glucose levels induces EC senescence [72], in vivo evidence of increased senescence has been provided in atherosclerotic plaques and kidney tissue of diabetes patients, suggesting the relevance of this phenomenon to T2DM vascular complications [73, 74].”
BackgroundDamage-associated molecular patterns and their pathological relevance in diabetes mellitus
Shin, J. J., Lee, E. K., Park, T. J., & Kim, W. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.06.004 · Cited by 74 · cited 1×
“The NOD-like receptor- (NLR-) caspase 1-IL-1β cascade can be activated by endogenous metabolism or injury-derived byproducts called damageassociated pattern molecules (DAMPs), resulting in chronic secretion of inflammatory cytokines [77].”
BackgroundRedox Control of the Senescence Regulator Interleukin-1α and the Secretory Phenotype
McCarthy, D. A., Clark, R. R., Bartling, T. R., Trebak, M., & Melendez, J. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.493841 · Cited by 73 · cited 1×
“…to completely suppress the increased death rate of diabetic patients, we propose a SASP-centered view of T2DM as a futuristic therapeutic option, possibly opening new prospects by moving the attention from one-organ studies of diabetes complications to a wider targeting of the aging process.”
BackgroundPrajapati, B., Jena, P. K., Rajput, P., Purandhar, K., & Seshadri, S. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666140515112609 · Cited by 73
50 years forward: mechanisms of hyperglycaemia-driven diabetic complications
Russell, N., & Cooper, M. E. (2015) · Diabetologia · doi:10.1007/s00125-015-3600-1 · Cited by 68 · cited 3×
“[90] N.”
BackgroundInfluentialSpazzafumo, L., Olivieri, F., Abbatecola, A. M., Castellani, G., Monti, D., Lisa, R., Galeazzi, R., Sirolla, C., Testa, R., Ostan, R., et al. (2011) · AGE · doi:10.1007/s11357-011-9348-8 · Cited by 61 · cited 1×
“In type 2 diabetes mellitus (T2DM), many elements of aging appear earlier or are overrepresented, including consistent inflammaging.”
BackgroundSelf-citationβ‐Galactosidase—An indicator of the maturational stage of mouse and human mononuclear phagocytes
Brusuker, I., Rhodes, J. M., & Goldman, R. (1982) · Journal of Cellular Physiology · doi:10.1002/jcp.1041120312 · Cited by 57 · cited 1×
“These findings clearly point at the endothelium as a key organ in the pathophysiology of aging and in diabetes complications.”
BackgroundFerrand, M., Kirsh, O., Griveau, A., Vindrieux, D., Martin, N., Defossez, P., & Bernard, D. (2015) · Aging · doi:10.18632/aging.100845 · Cited by 56 · cited 1×
“These findings clearly point at the endothelium as a key organ in the pathophysiology of aging and in diabetes complications.”
Strazhesko, I. D., Ткачева, О. Н., Boytsov, S. A., Akasheva, D. U., Dudinskaya, Е. N., Vygodin, V. A., Skvortsov, D. A., & Nilsson, P. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136676 · Cited by 47 · cited 2×
“[64] I.”
Zhu, B., Ferry, C. H., Markell, L. K., Blazanin, N., Glick, A. B., Gonzalez, F. J., & Peters, J. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551069 · Cited by 47
Proinflammation of Aging Central Arteries: A Mini-Review
Wang, M., Monticone, R. E., & Lakatta, E. G. (2014) · Gerontology · doi:10.1159/000362548 · Cited by 42 · cited 1×
“There is growing epidemiological evidence that a state of mild inflammation is associated with and predicts several age-related diseases (ARDs), including type 2 diabetes mellitus (T2DM) and its complications (e.g., cardiac death) [3–5].”
BackgroundEndothelial cell heterogeneity and atherosclerosis
Aird, W. C. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0067-z · Cited by 35 · cited 1×
“7000m(2)) suggest that SASP acquisition by these cells must exert a strong effect at the systemic level [21].”
BackgroundBeisswenger, P. J., Brown, W. V., Ceriello, A., Le, N., Goldberg, R. B., Cooke, J. P., Robbins, D. C., Sarwat, S., Yuan, H., Jones, C. A., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03324.x · Cited by 29
Self-citationShort telomere length is associated with arterial aging in patients with type 2 diabetes mellitus
Dudinskaya, Е. N., Tkacheva, O. N., Shestakova, M. V., Brailova, N. V., Strazhesko, I. D., Akasheva, D. U., Isaykina, О. Y., Шарашкина, Н. В., Kashtanova, D. A., & Boytsov, S. A. (2015) · Endocrine Connections · doi:10.1530/ec-15-0041 · Cited by 28 · cited 1×
“Finally, a strong association has been highlighted between telomere length and the presence of some diabetes complications and general arterial aging [66, 67].”
BackgroundPrattichizzo, F., Bonafè, M., Çeka, A., Giuliani, A., Rippo, M. R., Re, M., Antonicelli, R., Procopio, A. D., & Olivieri, F. (2016) · Current Drug Targets · doi:10.2174/1389450116666150804105659 · Cited by 26 · cited 1×
“We have designated the secretory phenotype acquired by ECs “endo-SASP” [19].”
BackgroundSelf-citationPathogenetic Loop Between Diabetes and Cell Senescence
Testa, R., & Ceriello, A. (2007) · Diabetes Care · doi:10.2337/dc07-1534 · Cited by 24 · cited 1×
“Consequently, senescent cells might be part of a pathogenic loop both as a cause and a consequence of metabolic changes and tissue damage in diabetes [56, 62].”
BackgroundSelf-citationEndothelium Under Stress: Local and Systemic Messages
Brodsky, S. V., & Goligorsky, M. S. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.02.005 · Cited by 22 · cited 1×
“low ROS levels in vivo (hormesis) [102, 103].”
Pujadas, G., Nigris, V. D., Sala, L. L., Testa, R., Genovese, S., & Ceriello, A. (2015) · Endocrine · doi:10.1007/s12020-015-0799-z · Cited by 17
Self-citationHong, Y., Quintero, M., Frakich, N., Trivier, E., & Erusalimsky, J. D. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.01.007 · Cited by 15 · cited 1×
“In ECs this has clearly been demonstrated for coenzyme Q10 [98], N-acetyl cysteine [99], and a stable vitamin C analog [100].”
BackgroundYin Yang: A Balancing Act for Oxidative Stress
Maiese, K. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.4.13340 · Cited by 3
Research works printed but not linked: 1
- 10.1073/pnas.1322153111/-/DCSupplemental · doi:10.1073/pnas.1322153111/-/dcsupplemental
Cited by
Ha, D. H., Kim, H.-K., Lee, J., Kwon, H. H., Park, G.-H., Yang, S. H., Jung, J. Y., Choi, H., Lee, J. H., Sung, S., et al. (2020) · Cells · doi:10.3390/cells9051157 · Cited by 539
“Thus, interventions that suppress SASP and inflammaging processes may hold potential to alleviate various chronic diseases [177].”
BackgroundInflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
Zuo, L., Prather, E. R., Stetskiv, M., Garrison, D. E., Meade, J. R., Peace, T. I., & Zhou, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184472 · Cited by 539
“Cellular senescence as well as the part it plays in vascular dysfunction and inflammation is a topic that is currently being extensively researched [199].”
BackgroundInfluentialEmerging Targets in Type 2 Diabetes and Diabetic Complications
Demir, S., Nawroth, P. P., Herzig, S., & Ekim Üstünel, B. (2021) · Advanced Science · doi:10.1002/advs.202100275 · Cited by 525
Lagoumtzi, S. M., & Chondrogianni, N. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.003 · Cited by 279
Obesity May Accelerate the Aging Process
Salvestrini, V., Sell, C., & Lorenzini, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00266 · Cited by 260
Metadata
- Authors
- Prattichizzo, F., De Nigris, V., La Sala, L., Procopio, A. D., Olivieri, F., & Ceriello, A.
- Affiliations
- Marche Polytechnic University (IT)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Corresponding author
- Prattichizzo, Francesco
- ORCID
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2016-01
- Volume
- 2016
- Issue
- 1
- Pages
- 1810327-1810327
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC4908264
- OpenAlex
- W2410474683
- Cited by
- 129
- References
- 126
- Citations by year
- 2026: 13 · 2025: 10 · 2024: 8 · 2023: 8 · 2022: 18 · 2021: 16 · 2020: 16 · 2019: 13 · 2018: 11 · 2017: 11 · 2016: 4
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Funders
- Università Politecnica delle Marche
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- inflammaging, senescence-associated secretory phenotype, type 2 diabetes, aging, low-grade inflammation, oxidative stress, endoplasmic reticulum stress, endothelial dysfunction, endothelial cells, diabetes complications, therapeutic target
- MeSH terms
- Aging, Animals, Diabetes Mellitus, Type 2, Humans, Inflammation, Phenotype, Oxidative Stress, Endothelial Cells, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.